甲状腺癌发病风险相关因素分析

doi:10.3760/cma.j.issn.1673-422X.2017.04.011

国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (4): 284-286.doi: 10.3760/cma.j.issn.1673-422X.2017.04.011

甲状腺癌发病风险相关因素分析

王佳峰,葛明华

310022 杭州，浙江省肿瘤医院头颈肿瘤外科

出版日期:2017-04-08 发布日期:2017-05-09
通讯作者: 葛明华 E-mail:gemingh@163.com
基金资助:
国家自然科学基金（81602349）

Analysis of risk factors of thyroid cancer

Wang Jiafeng, Ge Minghua.

Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China

Online:2017-04-08 Published:2017-05-09
Contact: Ge Minghua E-mail:gemingh@163.com
Supported by:
National Natural Science Foundation of China (81602349)

摘要/Abstract

摘要： 近十年，甲状腺癌发病率持续并快速增长，其发病风险因素成为社会关注的焦点。童年期电离辐射的暴露和遗传因素是甲状腺癌确定的风险因素；甲状腺肿、甲状腺良性结节或腺瘤和肥胖是甲状腺癌高度可能的风险因素；月经、生殖相关因素、饮食因素等是甲状腺癌可能的风险因素。

关键词: 甲状腺肿瘤, 发病率, 风险因素

Abstract: In the last decades, the incidence of thyroid cancer has continuously and rapidly increased, and the risk factors have become the focus of the whole society′s attention. The exposure of radiation in childhood and genetic predisposition are determinate risk factors for thyroid cancer. Goiter, benign nodules/adenomas and obesity are highly likely risk factors for thyroid cancer. Some menstrual and reproductive factors and dietetic factors are possible risk factors for thyroid cancer.

Key words: Thyroid neoplasms, Morbidity, Risk factors

王佳峰,葛明华. 甲状腺癌发病风险相关因素分析[J]. 国际肿瘤学杂志, 2017, 44(4): 284-286.

Wang Jiafeng, Ge Minghua.. Analysis of risk factors of thyroid cancer[J]. Journal of International Oncology, 2017, 44(4): 284-286.

参考文献

［1］ Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies［J］. Radiat Res, 2012, 178(2): AV43-AV60. DOI: 10.1667/RRAV05.1. ［2］ Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer［J］. Radiat Res, 2012, 178(4): 365-376. DOI: 10.1667/RR2889.1. ［3］ Williams D. Radiation carcinogenesis: lessons from chernobyl［J］. Oncogene, 2008, 27 Suppl 2: S9-S18. DOI: 10.1038/onc.2009.349. ［4］ Cardis E, Howe G, Ron E, et al. Cancer consequences of the chernobyl accident: 20 years on［J］. J Radiol Prot, 2006, 26(2): 127-140. DOI: 10.1088/09524746/26/2/001. ［5］ Memon A, Godward S, Williams D, et al. Dental x-rays and the risk of thyroid cancer: a case-control study［J］. Acta Oncol, 2010, 49(4): 447-453. DOI: 10.3109/02841861003705778. ［6］ Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence［J］. Epidemiology, 2009, 20(2): 181-187. DOI: 10.1097/EDE.0b013e318196ac1c. ［7］ Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American thyroid association［J］. Thyroid, 2009, 19(6): 565-612. DOI: 10.1089/thy.2008.0403. ［8］ Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer［J］. J Clin Endocrinol Metab, 2005, 90(10): 57475753. DOI: 10.1210/jc.2005-0935. ［9］ dos Santos Silva I. Swerdlow AJ. Sex differences in the risks of hormonedependent cancers［J］. Am J Epidemiol, 1993, 138(1): 10-28. ［10］ Negri E, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer-Ⅰ. Methods［J］. Cancer Causes Control, 1999, 10(2): 131-142. DOI: 10.1023/A:1008851613024. ［11］ Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors［J］. Cancer Causes Control, 2009, 20(1): 75-86. DOI: 10.1007/s10552-008-9219-5. ［12］ Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer［J］. Cancer Causes Control, 1999, 10(6): 583-595. ［13］ Singh B, Shaha AR, Trivedi H, et al. Coexistent hashimoto′s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome［J］. Surgery, 1999, 126(6): 1070-1076; discussion-1076-1077. ［14］ Kim KW, Park YJ, Kim EH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto′s thyroiditis［J］. Head Neck, 2011, 33(5): 691-695. DOI: 10.1002/hed.21518. ［15］ Anil C, Goksel S, Gursoy A. Hashimoto′s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid no-dules: a single-center prospective study［J］. Thyroid, 2010, 20(6): 601-606. DOI: 10.1089/thy.2009.0450. ［16］ Jankovic B, Le KT, Hershman JM. Clinical review: hashimoto′s thyroiditis and papillary thyroid carcinoma: is there a correlation?［J］. J Clin Endocrinol Metab, 2013, 98(2): 474-482. DOI: 10.1210/jc.2012-2978. ［17］ Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies［J］. Endocr Relat Cancer, 2009, 16(1): 17-44. DOI: 10.1677/ERC-08-0154. ［18］ Bosetti C, Kolonel L, Negri E, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅵ. Fish and shellfish consumption［J］. Cancer Causes Control, 2001, 12(4): 375-382. ［19］ Bosetti C, Negri E, Kolonel L, et al. A pooled analysis of case-control studies of thyroid cancer. Ⅶ. Cruciferous and other vegetables (International) ［J］.Cancer Causes Control, 2002, 13(8): 765-775. ［20］ FeldtRasmussen U. Iodine and cancer［J］. Thyroid, 2001, 11(5): 483-486. DOI: 10.1089/105072501300176435. ［21］ Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood［J］. J Natl Cancer Inst, 2005, 97(10): 724-732. DOI: 10.1093/jnci/dji129. ［22］ Knobel M, Medeiros-Neto G. Relevance of Iodine intake as a reputed predisposing factor for thyroid cancer［J］. Arq Bras Endocrinol Metabol, 2007, 51(5): 701-712. ［23］ Xu L, Port M, Landi S, et al. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three casecontrol studies［J］. Thyroid, 2014, 24(6): 966-974. DOI: 10.1089/thy.2013.0566. ［24］ Bhaskaran K, Douglas I, Forbes HA, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults［J］. Lancet, 2014, 384(9945): 755-765. DOI: 10.1016/S0140-6736(14)60892-8.

[1]	王子琪, 罗盼, 叶永英, 吴伟莉. 甲状腺腺样囊性癌1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(3): 191-192.
[2]	贺嘉慧, 胡钦勇. 基于GBD数据的中国和美国肺癌发病和死亡趋势及危险因素对比分析[J]. 国际肿瘤学杂志, 2024, 51(1): 29-36.
[3]	张劲男, 刘邦卿, 李军, 刘晓辉. BHLHE40靶向HMGA2激活氧化磷酸化通路降低甲状腺癌细胞对顺铂敏感性的研究[J]. 国际肿瘤学杂志, 2023, 50(7): 398-406.
[4]	赵倩雯, 彭丹莉, 秦韬, 毛国飞, 唐辉, 杨峻. 1990—2019年全球肿瘤发病死亡分析[J]. 国际肿瘤学杂志, 2023, 50(7): 425-431.
[5]	李劲浩, 王桂东, 李雪菲, 刘子琳, 孟凯龙. 静脉期CT值预测甲状腺乳头状癌中央组淋巴结转移的临床研究[J]. 国际肿瘤学杂志, 2022, 49(10): 581-585.
[6]	段帅, 郭晨明, 李慧芳, 地力木拉提·艾斯木吐拉. 1990—2019年中国女性乳腺癌发病死亡趋势及年龄-时期-队列模型分析[J]. 国际肿瘤学杂志, 2022, 49(10): 586-591.
[7]	吴宇平, 张潇宇, 陆克义. PD-L1在甲状腺癌中的作用机制及其在诊疗中的应用[J]. 国际肿瘤学杂志, 2021, 48(9): 560-563.
[8]	冯志平, 杨传周, 陈婷, 朱家伦, 刘超, 吕娟, 陆建梅, 邓智勇. BRD4抑制剂通过BRD4/miR-106b-5p/P21分子轴特异性抑制野生型Kras分化型甲状腺癌发展[J]. 国际肿瘤学杂志, 2021, 48(8): 463-472.
[9]	侯小锋, 薛金才, 田尤新, 刘勤江. 分化型甲状腺癌诊断与外科治疗四十年[J]. 国际肿瘤学杂志, 2020, 47(8): 449-456.
[10]	程虎, 刘名奎, 陈天平. 长非编码RNA AFAP1-AS1对甲状腺癌细胞增殖和侵袭的影响及其机制[J]. 国际肿瘤学杂志, 2020, 47(6): 327-332.
[11]	王家乐, 曹君. 甲状腺癌内科治疗进展[J]. 国际肿瘤学杂志, 2020, 47(4): 231-235.
[12]	张李卓, 钱杨洋, 郑国湾, 葛明华. PD-1/PD-L1在肿瘤中的机制研究及其在甲状腺癌中的诊治价值[J]. 国际肿瘤学杂志, 2020, 47(1): 39-42.
[13]	雷林，吉勇，尚庆刚，彭绩，任骅. 深圳市2001—2015年白血病流行特征和时间趋势[J]. 国际肿瘤学杂志, 2019, 46(7): 415-419.
[14]	武元元, 王军. 甲状腺未分化癌的靶向药物治疗进展[J]. 国际肿瘤学杂志, 2019, 46(2): 98-101.
[15]	董方, 薛金才, 王云生, 刘勤江. 甲状腺癌外照射放射治疗的变迁[J]. 国际肿瘤学杂志, 2019, 46(11): 641-648.

甲状腺癌发病风险相关因素分析

Analysis of risk factors of thyroid cancer

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价